Search Results - "Rothweiler, R."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Medication-related osteonecrosis of the mandible: an unusual presentation and treatment by Rothweiler, R., Voss, P.J., Schmelzeisen, R., Metzger, M.C.

    “…A 71-year-old woman was referred to the clinic with extensive medication-related osteonecrosis of the jaw (MRONJ) involving the mandible. She had received 7…”
    Get full text
    Journal Article
  3. 3

    Lymph node abscess caused by Francisella tularensis - a rare differential diagnosis for cervical lymph node swelling: a case report by Rothweiler, R, Fuessinger, M A, Schmelzeisen, R, Metzger, M C

    Published in Journal of medical case reports (09-08-2019)
    “…Cervical lymph node swelling is quite a common symptom mainly caused by infections in the face or as metastasis of a malignant tumor. In infection cases in…”
    Get full text
    Journal Article
  4. 4

    Interdisciplinary management of skull base surgery by Rothweiler, R., Metzger, M.C., Voss, P.J., Beck, J., Schmelzeisen, R.

    “…Skull base surgery remains one of the challenging areas in the field of cranio-maxillofacial surgery, otolaryngology and neurosurgery. Subsequent…”
    Get full text
    Journal Article
  5. 5

    Current guidelines on carotid artery stenting. Critical evaluation by Hein-Rothweiler, R, Mudra, H

    Published in Herz (01-11-2013)
    “…Scientific data underlying current guidelines on treatment of carotid artery stenosis is subject to interdisciplinary discussion. In particular selective…”
    Get full text
    Journal Article
  6. 6

    Implantatgetragener Zahnersatz bei Tumorpatientinnen by Höfer, O., Rothweiler, R. M., Spies, B. C.

    “…Zusammenfassung Patient*innen mit Tumoren im Kopf-Hals-Bereich leiden oft an ausgedehnten Defekten der Weichteile und/oder Knochen und dem Verlust von Zähnen…”
    Get full text
    Journal Article
  7. 7

    Aktuelle Leitlinien zum Karotis-Stenting: Kritische Beurteilung by Hein-Rothweiler, R., Mudra, H.

    Published in Herz (01-11-2013)
    “…Zusammenfassung Die den aktuellen Leitlinien zugrunde liegenden Studien zur Therapie der Karotisstenose sind Gegenstand interdisziplinärer Diskussionen…”
    Get full text
    Journal Article
  8. 8

    3293Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial by Rizas, K, Farhan, S, Huczek, Z, Merkely, B, Hein-Rothweiler, R, Vogel, B, Massberg, S, Huber, K, Aradi, D, Sibbing, D

    Published in European heart journal (01-10-2019)
    “…Abstract Background A de-escalation of P2Y12-inhibitor treatment guided by platelet function testing (PFT) has been identified as a safe and alternative…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Perkutaner Vorhofohrverschluss: Effektive und sichere Schlaganfallprophylaxe bei nicht-valvulärem Vorhofflimmern by Ledwoch, J., Hein-Rothweiler, R., Mudra, H.

    Published in Der Kardiologe (19-02-2015)
    “…Zusammenfassung Hintergrund Ein großer Teil der Patienten mit Vorhofflimmern erhält keine adäquate Schlaganfallprophylaxe oder ist mit den aktuellen…”
    Get full text
    Journal Article
  14. 14

    Perkutaner Vorhofohrverschluss by Ledwoch, J, Hein-Rothweiler, R, Mudra, H

    Published in Der Kardiologe (01-02-2015)
    “…HintergrundEin großer Teil der Patienten mit Vorhofflimmern erhält keine adäquate Schlaganfallprophylaxe oder ist mit den aktuellen Antikoagulanzien nicht…”
    Get full text
    Journal Article
  15. 15

    Methodological problems in studying psychotropic drugs with special reference of the AMP system by Baumann, U, Rothweiler, R, Scheidegger, P

    Published in Arzneimittel-Forschung (01-02-1975)
    “…There are several methodical problems that have to be coped with when testing psychotropic drugs in psychiatric clinics. In this paper some relevant problems…”
    Get more information
    Journal Article
  16. 16

    Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl) by Woggon, B, Angst, J, Gmuer, M, Hess, K, Hurwitz, E, Martens, H, Rothweiler, R, Steiner, A

    “…Effects and side-effects of 150 mg and 225 mg maprotiline per day were compared by means of a double-blind trial in 20 depressed inpatients. The first 2 days…”
    Get more information
    Journal Article
  17. 17